APA (7th ed.) Citation

L, L., S, G., LM, Ø., SH, R., B, M., J, A., . . . M, Ø. (2024). Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries. Arthritis care & research, 76(11), 1558. https://doi.org/10.1002/acr.25396

Chicago Style (17th ed.) Citation

L, Linde, et al. "Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries." Arthritis Care & Research 76, no. 11 (2024): 1558. https://doi.org/10.1002/acr.25396.

MLA (9th ed.) Citation

L, Linde, et al. "Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries." Arthritis Care & Research, vol. 76, no. 11, 2024, p. 1558, https://doi.org/10.1002/acr.25396.